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doi:10.1016/j.ejvs.2010.10.014Abstract Objective: Patient- and society-oriented measures of outcome have a critical role
in determining the effectiveness of any treatment in patients with critical limb ischaemia
(CLI). In particular, the impact of an intervention on patient’s dependency and functional
performance is relevant but is largely unknown.
The aim of the study was to investigate whether the limitations encountered in the activities
of daily living (ADLs) measured with the Katz Index (KI) in patients with CLI were changed by
the treatment.
Methods: During the period 2006e2008, 248 consecutive patients undergoing repair for CLI
were investigated with an ADL questionnaire for assessing KI before and after a mean of
16.19 months from treatment. Changes in KI were stratified by type of treatment and outcome.
Results: There were 165 males and 83 females, mean age 73.3  8.3 years; 125 patients
showed tissue loss and 123 rest pain alone, 98 received surgical bypass and 150 endovascular
repair. Pre-operative KI mean was 10.42. At the post-operative assessment, there was signifi-
cant worsening in patients’ functional outcome (mean KI decreased to 9.78) despite relief of
pain (81.5%), tissue healing (72%), good vessel patency (83.8%) and low amputation rate (9.7%).
Deterioration of KI was not significantly higher in patients undergoing endovascular repair.
Patients receiving major amputation started with worse pre-operative functional score (KI
mean 9.42) and did further deteriorate (KI mean 7.71) after demolition surgery. However,
patients who received successful revascularisation showed deterioration in the dependence
index.
Conclusions: Successful vascular treatment is not associated with improved functional ability
in patients with CLI, especially when already highly dependent in their activities. Largethe 2010 Annual ESVS Vascular Meeting, held in Amsterdam, 16e19 September.
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Functional Outcome in Critical Limb Ischaemia 257nationwide preventive and educational programmes should be implemented to prevent irre-
versible and severe health deterioration in populations with CLI.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Critical limb ischaemia (CLI) is a disease process with
tremendous cardiovascular burden. The care of patients
with CLI is not straightforward because many of them have
significant co-morbidities including diabetes, renal disease
and advanced age that further contribute to the overall
morbidity, mortality, dependency and poor life satisfaction.
Furthermore, CLI is associated with significant reduction in
health-related quality of life and, of more relevance, in
functional independency with reported patients’ percep-
tion status comparable to or worse than patients with
recent myocardial infarction or cancer. The decision to
perform a revascularisation procedure (whether by surgical
bypass or endovascular treatment) versus amputation or
treat with medical therapy alone remains a challenge.
To be effective, any intervention for CLI needs to be
measured within the global functional perception of health
and dependency.
Many standardised health measurement scales failed to
reliably consider the functional ability in patients with CLI.
Furthermore, the results of different studies using either
general health-quality instruments (e.g., Short Form 36
Health Survey (SF-36)) or more specific questionnaires (e.g.,
Vascular Quality of Life Questionnaire, VascuQol) did not
provide reliable information and comparable data and did
not assess impact of revascularisation on functional depen-
dency.1,2 Currently, there are no quality of life instruments
that have been standardised in a large patient population
requiring treatment for CLI and the Trans-Atlantic Inter-
Society Consensus Document on Management of Peripheral
Arterial Disease (TASC) claimed that specific instruments
capable of detecting improvement in functional outcome in
this patient population must be developed.3
The Katz Index of Independence in Activities of Daily
Living (ADL), commonly referred to as the Katz ADL, is one
of the most employed general instruments to assess func-
tional status as a measurement of the patients’ ability to
perform activities of daily living independently.4,5 This
instrument, largely validated in the elderly/geriatric pop-
ulation is simple, quick, easy to understand and complete
also for elderly patients, stroke populations and patients
with disabilities. Furthermore, it can be useful for
recording data retrospectively.
The purpose of this study was to document outcome of
functional status using a general ADL instrument after
revascularisation for CLI.
Methods
For the purpose of this study, all patients who provided
informed consent and underwent planned elective infrain-
guinal lower-extremity revascularisation between January
2006 and December 2008 for an indication of CLI were
investigated. Consecutive patients without a history of
primary amputation and who survived after the revascu-
larisation procedure were included. Criteria for inclusion
were CLI defined as ischaemic rest pain and/or gangrene ornon-healing ischaemic ulceration corresponding to cate-
gories 4, 5 and 6 of the Society of Vascular Surgery/Inter-
national Society for Cardiovascular Surgery (SVS/ISCVS)
standards6 and according to the TASC guidelines.3 In the
presence of diabetic patients, CLI was diagnosed by clinical
findings in combination with signs of diminished perfusion,
transcutaneous oxygenation (tcPO2) findings and radio-
logic/ultrasound diagnostics.
All revascularisation procedures, either by endovascular
or open surgery, were included for the analysis, regardless
of the specific inflow site, outflow site and conduit or stent
material/configuration. The included lesions were accord-
ing to the TASC classification type B, C or D for vascular
anatomy.3
Risk factors and co-morbidities
Risk factors and co-morbidities were registered prospec-
tively during the admission intake. Co-morbidities examined
included coronary artery disease (history of myocardial
infarction or angina), chronic obstructive pulmonary disease
(COPD), hypertension (history of hypertension or blood
pressure >140/90 mmHg on the pre-operative evaluation),
history of tobacco use (never; <1 year or current), hyper-
lipidaemia (total cholesterol level higher than 200 mg/dl or
when the patient took lipid-lowering drugs for history of high
cholesterol levels), diabetes mellitus (insulin dependent or
controlled by oral medications or diet) and renal disease
(normal, creatinine 1.5 mg/dl renal insufficiency, serum
creatinine >1.5 mg/dl or dialysis dependent). Procedure
details were also evaluated.
All patients received planned revascularisation and
unplanned re-interventions. Revascularisation procedures
were divided into percutaneous endovascular and bypass
graft (BG) repairs. Endovascular procedures were carried
out by conventional balloon dilatation of the target lesion
with or without stent placement, and were performed under
local anaesthesia with or without sedation. BG procedures
were performed according to standard vascular techniques
using preferably an autologous vein for crural BG. The
choice of revascularisation was left to the surgeon’s
discretion, according to extension and type of lesions.
Follow-up data
Vital statusandpatencywasconfirmedduring follow-upvisits
scheduled at 1 month and every 6 months after the revas-
cularisation. Follow-up data included vital status, patency of
the graft or target artery, amputation status and symptoms
(asymptomatic, claudication, rest pain or tissue loss). The BG
or endovascular target vessel patency was determined by
duplex ultrasound examination. ‘Patency’ was defined as
patency across the same limb segment by one or more addi-
tional procedures (preserving or not the original graft). The
decision to re-intervene and the type of re-interventionwere
driven by the SVS/ISCVS and TASC reporting standards.3,6
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The functional status was evaluated according to the func-
tional independence measure assessed with Katz ADL.5 This
was determined before and after the revascularisation proce-
dure by a physician trained in peripheral vascular diseases
through telephone interviews to all identified survivors. The
mean follow-up time from revascularisation to telephone
survey was of 16.19 10.75 months (range 6e36) after repair.
The Katz ADL is the instrument to assess functional status
as a measurement of the patient’s ability to perform
activities of daily living independently. The Index ranks
adequacy of performance in the six functions of bathing,
dressing, toileting, transferring, continence and feeding. In
more than 30 years since the instrument was developed, it
has been modified and simplified, and different approaches
to scoring have been used. However, it has consistently
demonstrated its utility in evaluating functional status in
the elderly population. In this study, patients were scored
from 0 to 2 (from the worse to the best) for independence in
each of the six functions, according to the following scale:
 Score 0: the patient is unable to do any part of the
activity;
 Score 1: the patient is able to complete the activity
with difficulty, which may or will lead to requirement
for assistance; and
 Score 2: the patient is able to complete the activity
without assistance.
A detailed description of the ADL questionnaire is
reported in Appendix.
In addition to the six functions of the ADL questionnaire,
patients were specifically questioned about presence of
rest pain and healing status of foot ulcers. Standardised
questions (regarding ulcer healing, pain, ambulation and
each of the KI-specific functions) were systematically asked
during the interview.
Statistical analysis
The data of functional outcome were presented as
mean  standard error. For the purpose of comparison
between predefined groups, t-test and analysis of variance
(ANOVA) were used.
Cumulative patency and limb salvage rates were calcu-
lated using the life-table method.
Pre-operative, intra-operative and post-operative vari-
ables (listed in Table 1) were examined with univariate and
multiple regression analysis for their influence on func-
tional outcome changes after revascularisation. In partic-
ular, four predefined groups of patients were investigated
for functional outcome changes according to: presence of
non-healing ulcer at baseline; type of revascularisation
procedures (endovascular or open BG); graft/target vessel
patency; and limb salvage status.
Independent associations of variables with functional
outcome were analysed with multiple regression and
logistic regression analyses. For logistic regression a change
of 2 in the KI score was assumed as a clinically relevant
outcome measure.Revascularisation procedures (endovascular and BG)
were analysed by intention-to-treat.
A value of p< 0.05 was considered statistically signifi-
cant. Statistical analyses were performed through a com-
puterised software package, Statistical Package for Social
Sciences (SPSS) 16.0 for Windows.
Results
Cohort characteristics
Between January 2006 and December 2008, 370 consecu-
tive patients were admitted for treatment of CLI at a single
vascular centre. Thirty-five patients were judged with no-
option CLI and received primary major amputation. Of the
remaining vascularised patients, 57 died early after revas-
cularisation and could not be assessed for post-operative
function, and 30 were not available to respond to ques-
tionnaires. A total of 248 patients with KI measured before
and after treatment represent the study population. There
were 165 males and 83 females; mean age was 73.3  8.3
years (range 47e91).
Demographic and co-morbidities are shown in Table 1.
Almost half the patients at baseline had non-healing ulcer
or tissue loss (nZ 125) and half showed rest pain with foot
integrity (nZ 123).
There were 150 primary endovascular procedures and 98
primary BGs.
Outcome and patency rate
After a mean of 16.9  10.75 months from revascularisation,
24 (9.7%) major amputations occurred. Patients were specif-
ically investigated for the persistence of pain and non-healing
ulcer: 46 (18.5%) patients were still rested-pain; in 90 (72%),
ulcer healing occurred, while in 35, tissue loss persisted.
Secondary procedures were performed in 59 patients: in
48, after endovascular repair (32%) and, in 11, after BG
(11.2%), pZ 0.003. In seven, two or more re-interventions
were performed.
According to life-table analysis at 24 months, cumulative
limb salvage rate was 90% and patency rate was 82%.
Cumulative patency rates at 24 months were signifi-
cantly higher after BG than after endovascular approach:
90% versus 77% (pZ 0.035), after BG versus endovascular
repair, respectively.
Functional outcome
At baseline, mean KI score was 10.42 þ 2.45. Baseline and
post-operative mean KI scores are shown in Table 1.
Baseline KI scores were worse in patients who underwent
amputation (9.42  2.70) and in those with persistent rest
pain (9.46 þ 2.89) or persisting non-healing ulcer
(9.77  2.78) after revascularisation(Table 1).
At post-operative assessment, mean KI significantly
deteriorated to 9.78  3.04 (difference 0.64); pZ 0.0001.
KI deterioration was detected in each of the specific score
functions, but was not significant for transfer (difference
0.06  0.49; pZ 0.055). For eating: difference 0.12; for
Table 1 Baseline and post-operative mean Katz Index scores.
n. % Mean pre-operative
Katz index
Mean post-operative
Katz index
D
Total Population 248 100 10.42 2.45 9.78 3.03 0.64
Male 165 66.5 10.44 2.38 9.84 2.96 0.6
Female 83 33.5 10.36 2.61 9.65 3.19 0.7
Diabetes 136 54.8 10.45 2.42 9.61 3.16 0.84
Hypertension 164 66.1 10.48 2.39 9.82 3.11 0.66
CADa 106 42.7 10.15 2.60 9.57 3.08 0.58
Hyperlipidemia 51 20.6 11.16 2.00 10.49 2.91 0.66
COPDb 43 17.3 10.53 2.45 9.67 2.69 0.86
Renal Failure 47 18.9 10.02 2.54 8.94 3.28 1.08
Smoking 106 42.7 10.60 2.34 10 3.00 0.6
Pre-operative foot integrity 123 49.6 10.41 2.40 9.89 3.10 0.52
Pre-operative non-healing ulcers 125 50.4 10.42 2.50 9.67 2.97 0.74
Endovascular Procedures 150 60.5 10.21 2.51 9.37 3.10 0.84
By-pass Graft 98 39.5 10.72 2.33 10.40 2.83 0.32
Patency 208 83.8 10.54 2.40 10 2.93 0.54
Loss of Patency 40 16.2 9.75 2.61 8.65 3.32 1.1
Limb Salvage 224 90.3 10.52 2.40 10.00 2.89 0.52
Major Amputation 24 9.7 9.42 2.70 7.71 3.55 1.7
Healing ulcers 90 72 10.67 2.36 10.36 2.59 0.31
Post-operative non-healing ulcers 35 28 9.77 2.78 7.91 3.20 1.85
Post-operative rest pain 46 18.5 9.46 2.89 7.91 3.41 1.54
a CAD (coronary artery disease).
b COPD (Chronic obstructive pulmonary disease).
Functional Outcome in Critical Limb Ischaemia 259dressing: difference 0.14, for bathing: difference 0.15
and for continence: difference 0.04 (Fig. 1).
Factors associated with changes in post-operative KI are
shown in Table 2. Significant KI deterioration with respect
to baseline was found for patients receiving endovascular
repair (difference 0.84; pZ 0.049); for patients who had
undergone amputation (difference 1.71; pZ 0.006) and
for patients with persisting rest pain (difference 1.54;
pZ 0.001). Statistical significance for endovascular repair
was lost when patients with re-interventions were censored
from the analysis (pZ 0.14).
At multiple regression analysis (Table 3), independent
predictors of KI change after repair were non-healing ulcer
at baseline (pZ 0.048; estimate 0.81; 95% confidence
interval (CI) 1.61 to 0.01), need of major amputation
(pZ 0.017; estimate 1.52; 95% CI e2.77 to 0.27),
healing ulcer after repair (pZ 0.003; estimate 1.22; 95% CI
0.41e2.02) and persistence of rest pain after repair
(pZ 0.01; score difference: 0.87; 95% CI e1.56 to 0.22).
Multiple logistic regression analysis using a clinical
relevant deterioration of 2 KI score change from baseline
as dependent variable confirmed the occurrence of major
amputation (pZ 0.02; odds ratio (OR) 11.66; 95% CI
1.48e91.94) and persistence of rest pain after revascular-
isation (p< 0.0001; OR 5.82; 95% CI 2.31e14.69) as inde-
pendent predictors.
Subgroup analysis
Changes in KI were analysed in subgroup analyses by pres-
ence of non-healing ulcer/tissue loss at baseline, type of
repair (endovascular vs. BG), patency and requirement of
amputation (Table 1).Deterioration was significant in each of the analysed
subgroups: for patients with non-healing ulcer/tissue loss at
baseline (p< 0.0001) and for those with foot integrity at
baseline (pZ 0.004); for patients with vessel patency
(pZ 0.0001) and those with patency loss (pZ 0.012); for
patients undergoing amputation (pZ 0.013) and those with
limb salvage (p< 0.0001).
In the analysis by treatment type, for patients receiving
endovascular treatment, KI changed from 10.21  2.51 to
9.37  3.10, difference 0.84 (p< 0.0001). For patients
receiving BG, KI changed from 10.72  2.33 to 10.40  2.83,
difference 0.32 (pZ 0.048). After censoring patients with
re-interventions, these figures became: for endovascular
group, KI changed from 10.39  2.44 to 9.51  3.13,
difference 0.88, (p< 0.0001); for the BG group, KI
changed from 10.90  2.29 to 10.44  2.86, difference
0.45 (pZ 0.008).Discussion
CLI is a chronic, evolving disease with inevitable progressive
degeneration and is associated with high rate of
hospitalisation and death and poor patient health percep-
tion. Most CLI patients have a tremendous disease burden,
with poor baseline function, loss of functional status and
ability to live independently.10,11 Impaired functional status
in patients with CLI is strongly associated with multiple
co-morbidities resulting in increased risk of death and
complications during revascularisation procedures.2,7e9
Furthermore, the poorer the baseline functional outcome
the worse the functional improvement, even after
successful revascularisation has been performed8e10:
Figure 1 Katz index pre and post revascularisation by specific function.
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same rate as the leg after successful revascularisation. In
our study, at the post-operative assessment, there was no
improvement in CLI patients’ functional outcome (mean KI
decreased by 0.64; pZ 0.0001) regardless of successful
revascularisation and vessel patency. Deterioration of KI
was strongly associated with more advanced disease stages
predisposing unsuccessful treatment as in patients with
baseline non-healing ulcer (pZ 0.048), in those requiring
major amputation (pZ 0.017) and in those with persistingTable 2 Factors associated with changes in post-operative Kat
Katz Index score mean variatio
Male 0.6
Diabetes 0.84
Hypertension 0.66
CADa 0.58
Hyperlipidemia 0.66
COPDb 0.86
Renal failure 1.08
Smoking 0.6
Pre-operative non-healing ulcers 0.74
Endovascular procedures 0.84
By-pass grafts 0.33
Patency 0.55
Major amputation 1.71
Post-operative healing ulcers 0.31
Post-operative rest pain 1.54
a CAD (coronary artery disease).
b COPD (Chronic obstructive pulmonary disease).non-healing ulcer (pZ 0.003) or persisting rest pain after
repair (pZ 0.010). Nevertheless, patients who received
successful revascularisation did not improve but showed
deterioration in the dependence index (from 10.54  2.40
to 10.00  2.94, difference 0.54; pZ 0.0001). These data
suggest that functional impairment is difficult to reverse
despite the treatment applied to recover the advanced
ischaemia of the limb.2,7,8,10 The best treatment to manage
patients with CLI should be the prevention of the advanced
disease.z Index score.
n Standard deviation 95% confidence interval p
Lower bound Upper bound
2.07 0.92 0.28 0.68
2.26 1.22 0.45 0.08
2.00 0.97 0.36 0.76
1.89 0.95 0.22 0.72
2.19 1.28 0.05 0.90
2.05 1.49 0.23 0.42
2.64 1.86 0.31 0.09
1.98 0.98 0.22 0.82
2.04 1.11 0.38 0.4
2.22 1.20 0.48 0.049
1.61 0.65 0.00 0.049
1.86 0.8 0.29 0.113
3.11 3.02 0.39 0.006
1.45 0.61 0 0.054
2.36 2.25 0.84 0.001
Table 3 Factors associated with changes in post-operative Katz Index score (multiple regression analysis).
Contract estimate 95% confidence interval p
Lower bound Upper bound
Male 0.18 0.37 0.72 0.52
Diabetes 0.27 0.77 0.23 0.28
CADa 0.19 0.30 0.69 0.44
COPDb 0.16 0.85 0.54 0.65
Renal failure 0.53 1.16 0.09 0.09
Smoking 0.25 0.79 0.30 0.37
Pre-operative non-healing ulcers 0.81 1.61 0.01 0.048
Endovascular procedures 0.42 0.94 0.11 0.12
Patency 0.57 1.58 0.43 0.26
Major amputation 1.52 2.78 0.27 0.017
Post-operative healing ulcers 1.22 0.41 2.02 0.003
Post-operative rest pain 0.89 1.56 0.22 0.01
a CAD (coronary artery disease).
b COPD (Chronic obstructive pulmonary disease).
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not translate into a more positive influence on functional
outcome in patients with CLI. Conversely, in our study,
despite the higher preference for an endovascular first
approach (nZ 150 endovascular vs. nZ 98 BG), there was
a trend towards higher functional deterioration after
endovascular treatment with respect to bypass surgery
(post-operative KI score difference from baseline: 0.84
vs. 0.32; pZ 0.049). The higher number of failures and
re-interventions might have likely affected the results after
the endovascular approach (nZ 48/150 vs. nZ 11/98, in
endovascular vs. BG groups, pZ 0.003). Indeed, after
censoring patients with re-intervention, the difference in KI
deterioration between endovascular and BG treatment
became not significant (pZ 0.14). Major surgery may
provide a better impact on functional outcome and may be
preferred above weeks of hospitalisation to undergo
repeated revascularisation attempts after first endovas-
cular approach. Accordingly, the randomised trial Bypass
versus Angioplasty in Severe Ischaemia of the Leg (BASIL)
recently showed a slight (even though transient and non-
significant) gain in quality of life perception in patients with
severe CLI assigned to bypass with respect to those assigned
to balloon angioplasty.12
In our experience, a number of patients (57/335) could
not be interviewed for functioning after a mean of 16.2
months from repair due to the high mortality rate from all
causes inherent to CLI disease. Ultimately, amputation is
often the only resolute option left to a subset of patients
with CLI, multiple co-morbidities and prohibitive mortality
whichever the treatment. However, even though limited in
numbers (amputation rate was 10% at 24 months), our results
demonstrated a detrimental effect of major amputation
after the attempt of revascularisation on functional status in
most patients with CLI. Nevertheless, patients undergoing
amputation started from poorer baseline functional score, as
an expression of more advanced disease (KI 9.42 vs. 10.52, in
amputation vs. limb salvage patients). Recent studies ana-
lysed the quality of life of patients with no-option CLI (CLI
without therapeutic options) and suggested an exceptionally
poor, far-behind-generalpopulation health perception scorein them.1 Our results can suggest that even in CLI with
options for therapy, the indication to treat might not be
worthwhile given the irreversible deterioration of functional
status of most CLI patients, persisting also after a successful
revascularisation procedure. Due to the poor and frequently
irreversible functional performance, the need for aggressive
interventional/surgical procedures and, thus, the need for
the development of new revascularisation strategies in
patients with advanced CLI might be questionable. A number
of new therapies such as administration of growth factors or
bone-marrow-derived stem cells that are currently being
evaluated in trials are most likely to provide illusive and not
definite solutions in patients with advanced CLI.
Prevention strategies are indeed consistently needed.
There is the need to implement patient care plans, phar-
macology strategies and patient-education programmes to
early and aggressively address risk factors associated with
poor outcome and worse functional ability in peripheral
vascular disease. A number of studies have investigated
factors associated with poor outcome in patients with
CLI.1,7,9 Several variables, including co-morbidities such as
diabetes and renal failure, foot lesion complexity/exten-
sion, technical complexity of revascularisation and nutri-
tional status, have been identified, most of which can be
pursued with aggressive early preventive strategies.
Indeed, patients with CLI characterise extremely compound
and multitasked entities. To address this complexity, we
used a generic geriatric health scale such as the Katz ADL to
provide an all-through evaluation of the functional ability
of patients with CLI.4,5 Even though the KI ranks perfor-
mance of six functions, some of which might seem mini-
mally affected by CLI, we did not intend to measure which
specific daily living function was affected by CLI but, more
likely, whether the overall functional disability of depen-
dent patients with CLI could be reversed with effective CLI
revascularisation, as this issue has a relevant burden on
social health and costs. Functional assessment is
a comprehensive evaluation of the physical and cognitive
abilities required to maintain independence and func-
tioning (“the ability to function in the arena of everyday
living”). Therefore, we did not intentionally use a specific
262 E. Cieri et al.CLI or a validated quality of life questionnaire, but we
applied a general instrument to assess functional perfor-
mance. Although the Katz ADL’s ability in measuring small
increments of change seen in the revascularisation of older
adults is limited (with respect to specific health-quality
questionnaires), little changes cannot reflect improve-
ments in function and dependency in CLI patients. Simi-
larly, the simple assessments of wound healing, pain relief
or vessel patency are all incomplete measurements of
successful treatment of CLI patients as a whole. In driving
appropriate indications for treatment of CLI, any invasive
treatment should be balanced by expected gain (or
prevention of loss) in health. A comprehensive patient
assessment including functional dependency is important to
evaluate the true impact of the successful treatment of CLI
on social health.
The Katz ADL is also very useful in creating a common
language regarding patient function for all problems and
has been validated in geriatric populations with chronic
disabilities such as after stroke or cancer.4,13 The social and
health burden of CLI in developed countries is comparable
to that of stroke as a similar high rate of disabilities is
provided while no effective treatment is available after the
occurrence of the disease, the best treatment option being
the prevention. It is of relevance that dependency recovery
might be more consistent after stroke than after CLI where
patient functional ability remains exceptionally poor over
time, confirming that CLI is a marker of a poor, irreversible
condition with high functional dependency and limited
opportunities for patient health improvement.
Limitations
There are two primary limitations in this study design. First,
although the data analysed in this study were prospectively
collected, questionnaires to assess functional outcome
were administered by telephone interviews and were
reviewed retrospectively. Nevertheless, the reliability of
our results was compensated for by low dropout rates.
Other studies prospectively analysing quality of life are
biased by higher rate of non-responders and those lost to
follow-up. As it is likely that the worse patients are those
who are non-responders and non-compliant with follow-up,
results from these studies might be overestimated.
Second, the patients were from a singe centre and the
size was limited to provide detailed information for
subgroups. Finally, there was no analysis of costs.
Conclusions
Most patients with CLI cannot adequately gain functional
advantages from revascularisation because of competing
co-morbidities. The successful lower-extremity bypass or
endovascular procedure does not translate into subsequent
functional dependency recovery.
In evaluating indications and benefits of invasive treat-
ments in CLI, functional outcome should be also consid-
ered. For patients with poorer functional status at baseline,
primary major amputation might be an option. Bypass
and endovascular procedure may be effective when the
impairment in CLI is not severe and the procedure can beperformed with minimal complications. Otherwise, large
nationwide preventive strategies of medical optimisation,
monitored risk factors and patient-education programmes
are more cost-effective tools to address the enormous
social health impact associated with CLI.
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